[2020] The Year to Ramp Up

PharmaCielo is expected to enjoy an exciting and transformative year in 2020. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Canada's PharmaCielo Blazes the Trail for Colombian Cannabis Market Matthew Carr | Chief Trends Strategist | The Oxford Club   How to Hit the Jackpot in the 5G Boom   An ongoing debate has captured the global cannabis market. We're all wondering... Will the industry ultimately be worth $200 billion... $500 billion... or - with everything considered - far more than that? There are dozens of companies battling it out to stake their claims and rise to dominance. For the past six years, cannabis company PharmaCielo (OTC: PHCEF) has been quietly building out its operations. Mainstream investors might not recognize the name. But that could soon change. Because all of the hard work the company has been doing is about to pay off. PharmaCielo's corporate headquarters is in Canada. But its medical marijuana grow operations are based in Colombia. There, the company has 150 registered strains, as well as one of the largest cannabis operations on the planet. And over the past several months, the company's operations have been gaining steam. PharmaCielo has increased its oil processing capacity by twelvefold. It can now handle 265 metric tons of dried flower every year. It also received the final permit to begin exporting CBD from Colombia. This is an enormous opportunity. And the company delivered its first commercial CBD shipment to Europe in August. So as we head into 2020, PharmaCielo is expected to enjoy an exciting and transformative year. That's why I thought now was a perfect time to talk to Chief Corporate Officer David Gordon. In this episode of CannaBiz Now!, he explains why Colombia offers cannabis growers advantages seen nowhere else in the world - and how the company is leveraging those advantages for its global market strategy. We also talk about the company's entrance into the U.S. market and the opportunities there. And David discusses the benefits of being headquartered in Canada. Finally, he outlines the obstacles and opportunities that PharmaCielo sees for the global cannabis market in the years ahead. Click here to tune in. Here's to high returns, Matthew       The Energy Disruption Triangle: Prepare for the Revolution David Fessler | November 6, 2019 Three elements are disrupting the way we generate, use and store electricity. Read More   Total Student Loan Debt in the United States Squashes American Dream Matthew Carr | November 4, 2019 Americans are buckling under the burden of $1.56 trillion in outstanding student debt. Read More   Invest in 5G Technology Matthew Carr | October 31, 2019 For any investor intrigued by the possibilities of 5G, this video is a great introduction. Read More   "Put thousands of dollars into your bank account" The new No. 1 Amazon bestseller by "America's No. 1 Retirement Expert" can help you pocket $50K in the year ahead. The CEO of Curzio Research confirmed that the income secrets inside the book can "literally put thousands of dollars into your bank account starting right now." Click here if you'd like to get the hardcover FREE today.     You are receiving this email because you subscribed to Profit Trends. To unsubscribe from Profit Trends, click here. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Profit Trends | Attn: Member Services | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Website: profittrends.com Keep the emails you value from falling into your spam folder. Whitelist Profit Trends. © 2019 The Oxford Club LLC All Rights Reserved   The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.